BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 125 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $133,331 | +27.6% | 18,832 | +26.9% | 0.01% | +25.0% |
Q2 2023 | $104,488 | -15.6% | 14,842 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $123,782 | -21.5% | 14,842 | 0.0% | 0.01% | -16.7% |
Q4 2022 | $157,770 | -9.8% | 14,842 | +6.5% | 0.01% | -25.0% |
Q3 2022 | $175,000 | +19.0% | 13,940 | 0.0% | 0.01% | +33.3% |
Q2 2022 | $147,000 | -35.2% | 13,940 | 0.0% | 0.01% | -25.0% |
Q1 2022 | $227,000 | +17.6% | 13,940 | 0.0% | 0.01% | +14.3% |
Q4 2021 | $193,000 | -3.5% | 13,940 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $200,000 | -9.1% | 13,940 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $220,000 | +43.8% | 13,940 | -7.4% | 0.01% | +33.3% |
Q1 2021 | $153,000 | +36.6% | 15,052 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $112,000 | +115.4% | 15,052 | 0.0% | 0.01% | +150.0% |
Q3 2020 | $52,000 | -14.8% | 15,052 | +18.2% | 0.00% | -33.3% |
Q2 2020 | $61,000 | +144.0% | 12,730 | 0.0% | 0.00% | +200.0% |
Q1 2020 | $25,000 | -43.2% | 12,730 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $44,000 | +83.3% | 12,730 | +53.4% | 0.00% | +100.0% |
Q3 2019 | $24,000 | -22.6% | 8,297 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $31,000 | -54.4% | 8,297 | 0.0% | 0.00% | -66.7% |
Q1 2019 | $68,000 | +1.5% | 8,297 | 0.0% | 0.00% | -25.0% |
Q4 2018 | $67,000 | +6.3% | 8,297 | 0.0% | 0.00% | +33.3% |
Q3 2018 | $63,000 | +31.2% | 8,297 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $48,000 | +20.0% | 8,297 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $40,000 | +21.2% | 8,297 | +23.9% | 0.00% | 0.0% |
Q4 2017 | $33,000 | -2.9% | 6,697 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $34,000 | -8.1% | 6,697 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $37,000 | -21.3% | 6,697 | +19.7% | 0.00% | 0.0% |
Q1 2017 | $47,000 | – | 5,597 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |